Loading…
Loading…
Sell-side consensus EPS, revenue estimates, YoY growth, forward P/E, and per-year analyst coverage — for any covered stock.
Click below to see what's inside, then upgrade to unlock for this and 80,000+ other tickers.
A year-by-year projected price path from the sell-side EPS consensus, with an editable target P/E and the implied annual return from today's price.
Click below to see what's inside, then upgrade to unlock for UPM.HE and 80,000+ other tickers.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for UPM.HE and 80,000+ other tickers.
See exactly how UPM.HE's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for UPM.HE and 80,000+ other tickers.
UPM-Kymmene Oyj, established in 1871 and headquartered in Helsinki, Finland, is a global player in the forest-based bioindustry. The company organizes its diverse operations across several key segments, including UPM Biorefining, UPM Energy, UPM Raflatac, UPM Specialty Papers, UPM Communication Papers, UPM Plywood, and other business areas. UPM is a significant producer of wood-derived materials, supplying softwood, birch, and eucalyptus pulp used in the creation of tissue, specialty, graphic papers, and packaging. It also provides sawn timber for various applications in joinery, packaging…
No recent news available.